Aralez
Latest round
- Series A
Last raised
- Jun 2024
Total raised
- $12M
Investors
- 9
About Aralez
, aka Aralez Bio specializes in the development and manufacture of noncanonical amino acids. Tina Boville (CEO), David Romney (CTO), and Frances Arnold are the co-founders of the company. Aralez Bio specializes in the development and manufacture of noncanonical amino acids, which are essential components utilized in biotechnology and pharmaceuticals. The firm’s unique enzymatic technology enables the production of these amino acids. The company's offerings cater to a diverse clientele, including pharmaceutical companies, peptide manufacturers, and research organizations, addressing needs in peptide synthesis, small molecule design, and drug conjugates, thereby contributing to advancements in next-generation therapeutics. Aralez Bio serves a global market with customers across North America, Europe, and Asia. Aralez Bio generates revenue primarily through B2B transactions with pharmaceutical companies and biotech firms. Their customer engagement involves partnerships and direct sales where clients access tailored solutions for amino acid production.
Who invested in Aralez
9 investors across 1 round
See all investors in Aralez
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 4, 2024
Amount
$12M
Investors
Questions about Aralez
Who invested in Aralez?
Aralez has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aralez raised?
Aralez has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aralez last raise money?
Aralez's most recent round on record is a Series A, in Jun 2024.
What does Aralez do?
, aka Aralez Bio specializes in the development and manufacture of noncanonical amino acids.
Where is Aralez headquartered?
Aralez is headquartered in San Leandro, US.
Which VCs invest in companies like Aralez?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aralez's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Aralez? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.